Skip to content

Prognostic value of the CALLY score for mortality and organ dysfunction in patients with acute brain injury: A validation study in MIMIC-IV, eICU, and a single center

Prognostic value of the CALLY score for mortality and organ dysfunction in patients with acute brain injury: A validation study in MIMIC-IV, eICU, and a single center

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118998
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-02-21
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Brain Injury

Interventions

Observation group:None

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: This study included patients aged 18 years and older who met the following criteria: 1. Diagnosed with ABI (including subarachnoid hemorrhage, intracerebral hemorrhage, etc.) at ICU admission or during ICU treatment; 2. Met the criteria for calculating the CALLY index (albumin level, lymphocyte count, C-reactive protein level) at ICU admission or during ICU treatment; 3. Had a GCS score <=12 at ICU admission or at the initial time of ICU treatment.

Exclusion criteria

Exclusion criteria: 1.Patients with an ICU stay of less than 72 hours or those who died on the day of ICU admission, resulting in insufficient data for analysis. 2.Patients with severe concurrent systemic diseases and an expected survival of less than 3 months (e.g., advanced malignant tumors, end-stage liver or kidney failure). 3.Patients with conditions that significantly affect inflammatory markers, such as active infections, systemic autoimmune diseases, or hematological disorders. 4.Patients with a history of significant neurological deficits that may affect prognosis assessment (e.g., pre-existing mRS score >= 2). 5.Patients with missing or unreliable critical data (e.g., incomplete hematological test results). 6.Patients for whom outcomes could not be assessed due to early discharge following treatment withdrawal. 7.Patients who received specific treatments during the current hospitalization that may affect the study indicators (e.g., investigational drugs, surgeries, etc.).

Design outcomes

Primary

MeasureTime frame
28-day and 365-day survival status;

Secondary

MeasureTime frame
ICU length of stay;Total length of stay;

Countries

China

Contacts

Public ContactDeng Shuixiang

Huashan Hospital, Fudan University

shuixiang2@126.com+86 21 52887353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026